[ Price : $8.95]
FDA says voluntary submission of clinical study diversity action plans increased from FY 2023 to FY 2024.[ Price : $8.95]
FDA warns Austin, TX-based XO Biologix that it is marketing an unapproved adulterated and misbranded product derived from amniotic...[ Price : $8.95]
FDA grants fast-track designation to posdinemab, an investigational J&J Alzheimers drug.[ Price : $8.95]
A CDER drug approval reports shows that first-cycle NDA approvals fell in 2024 to 74% (37 of the 50 novel drugs approved) from 84%...[ Price : $8.95]
FDA asks members of its Anesthetic and Analgesic Drug Products Advisory Committee to discuss several challenges the agency has ide...[ Price : $8.95]
Vanda Pharmaceuticals criticizes FDA for failing to approve the companys NDA for tradipitant to treat the symptoms of gastroparesi...[ Price : $8.95]
FDA warns Indias Indoco Remedies about repeat CGMP violations in its production of finished drugs.[ Price : $8.95]
FDA publishes a draft guidance with recommendations on clinical trials for drugs and biologics to treat obesity and overweight.